Biocon jumped 5.93% to Rs 340.30 after the U.S. Food and Drug Administration (FDA) has classified Biocon Biologics' facilities at Biocon Park in Bengaluru, as 'voluntary action indicated' (VAI). The ...
The combined cGMP inspection and pre-licensing inspection (PLI), which took place between July 15 and July 26, 2024, is the ...
Alembic Pharmaceuticals Limited announced today it has received final approval from the US Food & Drug Administration (USFDA) ...
Cipla’s FDA-compliant facilities and its investments in US-based units place it in a strong position to weather potential ...
Bengaluru: Biocon has announced that the U.S. Food and Drug Administration (FDA) has classified Biocon Biologics' facilities ...
I have long held the belief that digital therapeutics will be prescribed alongside drugs to improve patient outcomes, leading ...
Biocon shares surged 5.4% after FDA classified its Bengaluru facility as Voluntary Action Indicated (VAI). The stock is up 47 ...
These capsules will be available in dosages of 120 mg, 180 mg, 240 mg, 300 mg, and 360 mg, offering a generic alternative to ...
The FDA is proposing the removal of phenylephrine, a popular nasal decongestant, in oral form from over-the-counter use. Here ...
The American Heart Association is highlighting the importance of continuous care for individuals with congenital heart ...
We recently published a list of 10 Best Stocks to Buy According to Billionaire Ken Fisher. In this article, we are going to ...
Robert F. Kennedy Jr., who is lined up to advise the incoming Trump administration on its health policy agenda, has floated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback